In the autumn of 1989 the eosinophiliamyalgia syndrome (EMS) was recognised to be associated with the use of L-tryptophan. The In May 1988 a 45 year old woman was given L-tryptophan, 3 g nightly, for insomnia and persistent lower back pain. Sixteen months later she developed a macular rash on her forearms, thickening of the skin, and persistent low grade fever associated with increasing fatigue and weakness. In addition, she developed severe lancinating pains in her hands and feet. The peripheral blood eosinophil count was > 4000 cells/mm3. A full thickness skin biopsy showed fasciitis with lymphocytic infiltrates. A diagnosis of tryptophan induced EMS was made, L-tryptophan was discontinued, and prednisone 25 mg daily was started. The rash and fevers abated and the peripheral eosinophilia disappeared; however, the pain persisted, and the weakness progressed such that by December 1989, she was bed bound. Her history revealed hypothyroidism and a remote episode of "fever of unknown origin". The family history was negative for any neuromuscular disease. She was admitted to the Johns Hopkins Hospital in February 1990. On admission she was an ill appearing woman with thickened, leathery skin. Her hands and face were swollen, and her feet and legs were oedematous and discolored. There were flexion contractures at the elbows and knees, and the "groove" sign (branching pattern of collapsed veins, reflecting the absence of dermal fibrosis at venous sites, next to otherwise sclerodermatous skin7) was present on her arms. Her lungs were clear to auscultation but breath sounds were diminished. She had mild facial diplegia and ptosis but full extraocular movement. Proximal and distal limb muscles were weak: MRC grade 3 in the arms and proximal muscles of the legs and MRC grade 2 in distal leg muscles. She was unable to walk or sit up independently. Deep tendon reflexes were absent. Plantar responses were flexor. All sensory modalities were diminished in a stocking-glove pattern.
Arterial blood gas analysis showed hypoxia and a partially compensated respiratory acidosis (Pao2 71 mm Hg, Paco2 74 mm Hg, and pH 7 31). Vital capacity was 1 0 litre. A search for autoantibodies showed that the antiacetylcholine receptor antibody titre was 1-66 x 10-9 M (normal < 0 13 x 10-9 M), and the IgG anti-GM1 ganglioside titre was 2216 by ELISA (normal < 60; levels > 60 commonly associated with autoimmune disorders8 9). Normal laboratory results included the following: complete blood count, routine serum chemistries, complement, antinuclear antibodies, rheumatoid factor, creatine kinase, 26 ,ug/dl (normal, 5-0-130 ,ug/dl); and thyroid stimulating hormone, 32-9 mIu/ml (normal, 0 5-45 mIu/ml). IgM anti-GM1 ganglioside titre was 241 (normal, < 50; levels 50-350 commonly associated with autoimmune disorders), and IgG anti-GM1 ganglioside titre was 1612 (normal < 60; levels > 60 commonly associated with autoimmune disorders89). Normal results were obtained for analysis cerebrospinal fluid, electrolytes, transaminases, erythrocyte sedimentation rate, creatine kinase, hepatitis B and HIV serology, and antibodies to Ro and thyroglobulin.
A lip biopsy showed severe sclerosing inflammation of the minor salivary glands. There was squamous cell metaplasia of the remaining ducts, and most of the acini were destroyed. In the context of dry mouth, this pathology substantiated a diagnosis of Sjogren's disease.10 On the basis of electrophysiological and pathological data (presented below), a diagnosis of EMS and chronic demyelinating motor and sensory polyneuropathy was made.
The patient was given prednisone 50 mg daily, which resulted in mild improvement in her skin and her ability to walk. She continued to have difficulty swallowing and felt that her manual dexterity had worsened due to pain and stiffness. A four week course of plasma exchange (40-50 cc/kg twice weekly) was given but there was no measurable improvement.
The course was complicated by multiple compression fractures and continued pain. After one year of high dose prednisone, the dose was tapered and azathioprine (2) (3) (4) (5) Electromyography showed myopathic voluntary motor unit potentials without abnormal spontaneous activity in the proximal and distal muscles.
A follow up study was performed five weeks later. In all motor nerves the distal evoked amplitudes were reduced further than in the previous study. Distal latencies were further prolonged in the tibial and ulnar nerves, and conduction velocities were further reduced in all motor nerves. The F wave latency was prolonged in the tibial nerve and absent in the peroneal nerve. The results of surface recordings and stimulation in the left ulnar nerve suggested partial motor conduction block.
Case 2
The nerve conduction studies were interpreted as a demyelinating motor and sensory poly- (fig 1) . Both epineurium and endoneurium had scattered inflammation, and there was rimming of the perineurium with mononuclear cells. The density of large and small myelinated fibres was noticeably reduced. Many thinly myelinated fibres were seen, suggesting remyelination. One fascicle ( fig 1B) was extensively demyelinated, illustrating the inhomogeneous pattern of these changes. The epineurial and endoneurial blood vessel walls were thickened. Electron microscopy ( fig 1C, D) showed evidence of prior and active demyelination; some fibres had intratubal macrophages splitting myelin lamellae.
Examination of teased fibres confirmed extensive demyelination and remyelination; in one fascicle, 38% of fibres had demyelinated or demyelinating internodes; in a second fascicle, 8% of fibres were affected. By immunostaining for macrophage markers, the demyelinating fibres had adherent and intratubal macrophages ( fig IE) . Remyelinated fibres and fibres undergoing active Wallerian-like degeneration were also identified. Immunostaining of frozen Chronic demyelinating polyneuropathy associated with eosinophilia-nmalgia syndrome to the chronic use of L-tryptophan, but the exact pathophysiology is unknown. Speculation has centred on three hypotheses: (a) L-tryptophan may trigger an autoimmune response in some susceptible individuals;' 16 (b) EMS is due to a contaminant of some preparations of the drug; or (c) EMS may be due to faulty tryptophan metabolism. The autoimmune hypothesis may be supported by several notable features of these cases. Firstly, both patients, before being exposed to L-tryptophan, had a strong history of other disorders thought to be autoimmune. Secondly, after exposure to L-tryptophan both patients also had high concentrations of several autoantibodies in their serum samples. The presence of anti-acetylcholine receptor antibodies in patient 1 and anti-GMl antibodies in both patients does not necessarily imply that these patients had myasthenia gravis or multifocal motor neuropathy8 9; rather, it suggests that regulation of the immune system is disturbed. Thirdly, the temporal lag between drug discontinuation and the onset of the disease suggests an intervening mechanism (for example, autoimmunity) rather than a direct toxic mechanism. A fourth clinical feature that supports the autoimmune hypothesis is the apparent improvement of patient 1 after one course of intravenous gammaglobulin'9-22 and the dramatic improvement of patient 2 after four months of azathioprine treatment. Finally, inflammation was a prominent part of the neuropathology in both cases.
What is the pathophysiological relation between a demyelinating polyneuropathy and tryptophan associated EMS? While their coexistence may be due to chance, several speculative mechanisms may be considered. EMS or L-tryptophan might trigger a widespread autoimmune response, as suggested above. Or, as the morphological data presented here suggest, there may be more specific targeting by the immune system of peripheral nerve myelin, resulting in macrophage mediated demyelination. Perhaps L-tryptophan or a contaminant serves as an antigen or antigenic modifier (adjuvant), stimulating the immune system to recognise self antigens in peripheral nerve myelin. Those patients with EMS who developed demyelinating polyneuropathy may have a latent hypersensitivity to nerve antigen that is activated by the L-tryptophan preparation. Both our patients had a strong history of immune dysfunction which may have predisposed them to develop either demyelinating neuropathy or EMS. A similar mechanism was proposed in a patient with procainamide induced polyradiculopathy who showed lymphocyte sensitisation to peripheral nerve myelin and procainamide.23
The similarities between the neuropathy descibed in this paper and chronic inflammatory demyelinating polyradiculopathy (CIDP) should be noted because CIDP is generally considered to be a disorder of the immune 23 2 system. 24 Electrophysiologically, our patients' neuropathy was indistinguishable from CIDP.5 Clinically, both present with predominantly motor dysfunction and hypore- 
